We have also demonstrated that CTGF methylation levels were significantly decreased in patients with type 2 diabetic nephropathy, compared with type 2 diabetic patients without nephropathy or healthy control subjects, and that CTGF promoter methylation levels were negatively correlated with CTGF expressions [21]. This evidence concerns the gene CCN2 and type 2 diabetes mellitus.